论文部分内容阅读
目前分子靶向药物已成功地应用于肾癌临床治疗,且其不良反应的治疗也日益受到关注,本文就肾癌分子靶向治疗药物的不良反应及处理进行综述。
At present, molecular targeted drugs have been successfully applied to the clinical treatment of renal cell carcinoma, and the treatment of adverse reactions is also attracting more and more attention. This article reviews the adverse reactions and treatments of molecular targeted therapy of renal cell carcinoma.